共 50 条
Validation of the EntericBio Panel II® multiplex polymerase chain reaction system for detection of Campylobacter spp., Salmonella spp., Shigella spp., and verotoxigenic E. coli for use in a clinical diagnostic setting
被引:16
|作者:
Koziel, Monika
[1
]
Corcoran, Dan
[2
]
O'Callaghan, Isabelle
[2
]
Sleator, Roy D.
[1
]
Lucey, Brigid
[1
,2
]
机构:
[1] Cork Inst Technol, Dept Biol Sci, Cork, Ireland
[2] Cork Univ Hosp, Dept Microbiol, Cork, Ireland
关键词:
EntericBio;
Molecular detection;
PCR;
Campylobacter;
Salmonella;
Shigella;
E;
coli;
NON-O157 SHIGA TOXIN;
ESCHERICHIA-COLI;
PCR ASSAY;
IDENTIFICATION;
JEJUNI;
DIFFERENTIATION;
INFECTIONS;
TRENDS;
FETUS;
D O I:
10.1016/j.diagmicrobio.2012.09.007
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
A total of 717 faeces samples were tested prospectively using the EntericBio Panel II (R) detection system (Serosep, Limerick, Ireland), in parallel with routine laboratory testing, which combines the EntericBio (R) system with retrospective culture of each specimen where a target is detected. Discrepancy analysis was conducted using molecular methods. The EntericBio Panel II (R) assay produced 585 negative and 132 positive results, namely, Campylobacter spp. (n = 66); SLT 1 and/or SLT 2 (n = 64); Salmonella spp. (n = 5); and Shigella spp. (n = 0). Three samples were positive for more than 1 target. Of these results, 4 Campylobacter spp. detections and 4 SLT 1/SLT 2 detections remained unconfirmed, and the system failed to detect 2 Campylobacter spp. targets detected by routine laboratory detection. The sensitivity, specificity, positive predictive value, negative predictive value, and efficiency were calculated to be 98.4%, 98.7%, 93.9%, 99.7%, and 98.6%, respectively. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:46 / 49
页数:4
相关论文